2024

Greenwald MK (Jan 2024) Pharmacological rationale for high-concentration buprenorphine maintenance treatment, Providers Clinical Support System (PCSS), sponsored by the American Academy on Addiction Psychiatry (AAAP).

Greenwald MK (Jan 2024) Pharmacological rationale for high-concentration buprenorphine maintenance treatment”, sponsored by the Medical University of South Carolina ECHO group.

Greenwald MK, Burmeister M (June 2024) NMDA receptor subunit 2B (GRIN2B) genetic variation associated with opioid withdrawal symptom severity during buprenorphine induction. College on Problems of Drug Dependence annual meeting, Montreal, Quebec, Canada.

Huailei J, Roy P, Guo Y, Muzik O, Woodcock EA (June 2024) Automated radiosynthesis of [11C]CPPC for imaging neuroimmune state in humans. Society of Nuclear Medicine & Molecular Imaging, Toronto, Quebec, Canada.

Laffont CM, Saini A, Komalapriya C, Rengaswamy M, Bouchene S, Pendsey N, Purohit P, Horton T, Greenwald MK (June 2024) A mechanistic pharmacological model to predict and inform effective buprenorphine induction strategies in the era of synthetic opioids. College on Problems of Drug Dependence annual meeting, Montreal, Quebec, Canada.

Ledgerwood DM (April 2024) PTSD and Gambling. Iowa Department of Health and Human Services Problem Gambling Webinar Series.

Ledgerwood DM (April 2024) Updates on the Pathways Model. Iowa Department of Health and Human Services Problem Gambling Webinar Series.

Ledgerwood DM (May 2024) Trauma and gambling disorder. Evergreen Council on Problem Gambling annual conference, Portland, OR.

Ledgerwood DM (May 2024) Application of the Pathways Model of problem gambling to treatment. Evergreen Council on Problem Gambling annual conference, Portland, OR.

Ledgerwood DM (June 2024) CalGets Phase I problem gambling provider treatment. UCLA and the State of California.

Ledgerwood DM (June 2024) Connecting the dots: Why gambling researchers do what they do, and how can they inform practice? Keynote for the 21st Annual Midwest Conference on Problem Gambling and Substance Abuse, Kansas City, MO.

Ledgerwood (June 2024) Treating trauma and post-traumatic stress disorder among individuals with gambling disorder. 21st Annual Midwest Conference on Problem Gambling and Substance Abuse, Kansas City, MO.

Ledgerwood DM (under review) The only thing that matters is life or death. Understanding suicide in gambling disorder. National Council on Problem Gambling annual conference, San Diego, CA.

Mascarin A, Burmeister M, Greenwald MK (June 2024) Recent cocaine-use pattern and problem severity differs by corticotropin-releasing hormone receptor 1 (CRHR1) genotype. College on Problems of Drug Dependence annual meeting, Montreal, Quebec, Canada.

Tamimi RN, Zundel C, Ely S, Shampine M, O’Mara EC, Gowatch L, Bhogal A, Carpenter C, Woodcock EA, Marusak H (May 2024) Artifact mitigation in pediatric fMRI: enhancing data quality through multi-echo data acquisition and preprocessing. Society of Biological Psychiatry; Austin, TX.

Woodcock EA, Greenwald MK, Petriello MK, Lundahl LH, King AM, Muzik O (June 2024) Kynurenine pathway dysfunction in opioid use disorder: evidence from [11C]AMT PET imaging. College on Problems of Drug Dependence. Montreal, Quebec, Canada.

2023

Bonomi R, Hillmer AT, Woodcock EA, Angarita GA, Davis MT, Bhatt S†, Pietrzak R, Cosgrove KP (2023 Dec) Suppressed neuroimmune function in PTSD: evidence from PET imaging. American College of Neuropsychopharmacology; Tampa, FL.

Greenwald MK (2023 April) The latest on buprenorphine – pharmacology, formulations, and misconceptions. American Society of Addiction Medicine, “Pain & Addiction: Common Threads Pre-Conference Course”, National Harbor, MD.

Greenwald MK (2023 May) Neuropharmacological principles for effective buprenorphine induction in the ED setting. In: D’Onofrio G, Greenwald MK, Hawk K, Herring AA: “Buprenorphine in the era of fentanyl: truths, trends and treatments”. Society of Academic Emergency Medicine panel. Austin, TX.

Greenwald (2023 Dec 11) Pharmacological rationale for high-concentration buprenorphine: meet my friends delta, min, and sigma. SAMHSA/NIDA/FDA-sponsored virtual roundtable meeting on the need for high-dose buprenorphine treatment in the era of high-potency synthetic opioids.

Greenwald MK, Moses TEH (2023 June) Prediction of lifetime heroin overdose: injection use, quit attempts, suicidal ideation, and hepatitis. College on Problems of Drug Dependence, Denver, CO. Oral presentation.

Kouri N, Moses TEH, Lundahl LH, Greenwald MK (2023) Anhedonia and impulsivity modulate opioid use severity among persons in treatment for opioid use disorder. TNP Research Day.

Ledgerwood DM (October 2023) CalGETS Phase I Training for Treating Gambling Disorder. Invited workshop for the California Office of Problem Gambling and UCLA, Sacramento, CA.

Ledgerwood DM, Bedi DK, Bedi MK, Cannoy C, Prakash K, Foulon A, Excel S, Lundahl LH (2023) Reasons for electronic cigarette use questionnaire: development and initial analysis. Society for Research on Nicotine and Tobacco.

Morrison M, Jackson L, Cunningham PB, Randall J, Halliday C, Ledgerwood DM, Ryan-Pettes SR (submitted) Exploring the collateral benefits of contingency management. American Psychological Association, Washington DC.

Thomas H, Lundahl LH, Greenwald MK (2023 June) Effect of cannabidiol on subjective indices of morphine abuse liability. College on Problems of Drug Dependence, Denver, CO. Oral presentation.

Woodcock EA, Greenwald MK, Lundahl LH, Diwadkar VA (July 2023) Smoking cues and acute stress modulate working memory among smokers: a pharmaco-imaging study. Organization for Human Brain Mapping; Montreal, QC.

2022

Bechtold J, Ledgerwood DM (2022 April) Ethics in the modern world. Invited presentation for the Illinois Summit on Problem Gambling.

Greenwald MK (2022 Sept 6) Post-overdose buprenorphine induction following naloxone-precipitated withdrawal. NIDA Clinical Trials Network meeting on “Prehospital treatment for opioid use disorder”.

Greenwald MK (2022 March 27) Psychopharmacological management of opioid use disorder in the era of fentanyl. Virtual oral presentation to the annual meeting of the American Society of Clinical Psychopharmacology, Los Angeles, CA.

Greenwald MK, Moses TEH† (2022 June 13) Mu-opioid receptor epigenetics in persons with opioid use disorder: a pilot study. College on Problems of Drug Dependence annual meeting. Oral presentation.

Ledgerwood DM (2022 March) Recent research on the treatment of gambling disorder and co-occurring disorders. Invited talk for the Oklahoma Association on Problem Gambling & Gaming, Norman, OK.

Ledgerwood DM (2022 June) Contingency management for recovery houses. Invited presentation for the Fletcher Group Rural Center of Excellence, Building Rural Recovery Ecosystems Summit.

Ledgerwood DM (2022 July ) Treating co-occurring gambling disorder and other mental health problems. Invited presentation for the Responsible Gaming Association of New Mexico annual conference.

Ledgerwood DM, Bold KW, Deng Y, Dziura J, Porter E, Sigel KM, Yager JE, Bernstein SL, Edelman EJ (2022 June) Clinical pharmacist-delivered contingency management to promote smoking cessation among persons with HIV: initial experiences from the SMARTTT Trial. College on Problems of Drug Dependence annual meeting.

Ledgerwood DM, Najavits LM, Afifi TO (2022 July) Treatment of co-occurring gambling disorder and trauma: a randomized controlled trial comparing seeking safety to cognitive behavior therapy. National Council on Problem Gambling annual meeting.

Moses TEH, Harrison T, Waineo E, Greenwald MK (2022 Nov) Medical student experiences and perceptions of substance use among healthcare workers. AMERSA meeting.

Shaheen R†, Moses TEH†, Waineo E, Greenwald MK (2022 Nov) Experiences and characteristics that influence medical students’ desire to work with patients with substance use disorder. AMERSA meeting.

Weinstock J, Ledgerwood DM (2022 July) A primer on cognitive behavior therapy for gambling disorder. Workshop at the National Council on Problem Gambling conference, Boston, MA.

Woodcock EA, Diwadkar VA, Lundahl LH, Khatib D, Greenwald MK, Stanley JA (2022) Smokers exhibit less glutamate modulation in the dorsolateral prefrontal cortex during working memory than non-smokers: an 1H fMRS study. 77th annual meeting of the Society for Biological Psychiatry conference, New Orleans, LA.

2021

Greenwald MK, Moses TEH†, Burmeister M (2021) Corticotropin releasing hormone receptor 1 (CRHR1) genetic variation associated with binge use and problem severity among regular cocaine users. College on Problems of Drug Dependence. {virtual talk}

Moses TEH†, Chammaa M†, Moreno J, Ramos R†, Waineo E, Greenwald MK (2021) Unique impacts of opioid overdose prevention and response training on medical student knowledge and attitudes. AAMC conference.

Moses TEH†, Moreno J, Chammaa M, Waineo E, Greenwald MK (2021) Can 1-hour leave a lasting impression? Evaluating the unique contributions of opioid overdose prevention and response training to the pre-clinical medical curriculum. WSU Medical Education Conference.

Moses TEH†, Moreno J, Greenwald MK, Waineo E (2021) Evaluating the efficacy of in-person versus online training in opioid overdose prevention and response training, Association of Directors of Medical Student Education in Psychiatry (ADMSEP) conference.

Moses TEH†, Moreno J, Greenwald MK, Waineo E (2021) Evaluating the efficacy of in-person versus online training in opioid overdose prevention and response training, AAMC conference.

Moses TEH†, Shaheen R†, Lundahl LH, Waineo E, Greenwald MK (2021) What incoming medical students think about medical marijuana: a survey of attitudes and knowledge. AMERSA meeting.

Moses TEH†, Waineo E, Greenwald MK, Levine D (2021) Adapting buprenorphine waiver training for undergraduate medical education: medical student responses and attitudes. AMERSA meeting.

Plantegenest G, Bennett L, Strutz K, Greenwald MK, Heeringa C, Bunker H, Poland C (2021) MI CARES: an innovative online program to support addiction medicine certification. CGEA 2021 conference.

Syed S†, Moses TEH†, Culver L†, El-Sayed W†, Waineo E, Greenwald MK (2021) The role of race/ethnicity on knowledge of and attitudes towards opioid overdose and harm reduction. AAMC Conference.

Woodcock EA, Angarita GA, Matuskey D, Ropchan J, Nabulsi N, Huang H, Hillmer AT, Carson RE, Cosgrove KP (2021) A translational investigation of morphine-induced neuroimmune signaling: implications for opioid use disorder. American College of Neuropsychopharmacology.

Woodcock EA, Diwadkar VA, Lundahl LH, Khatib D, Greenwald MK, Stanley JA (under review) Smokers exhibit less glutamate modulation in the dorsolateral prefrontal cortex during working memory than non-smokers: an 1H fMRS study. Society for Biological Psychiatry conference.

2020

Barrientos K, Moses TEH, Gloystein T, Waineo E, Greenwald MK (2020) The impact of personal experience with substance use disorders on first-year medical students’ knowledge and attitudes toward opioid use disorders. WSU Medical Education Research and Innovation Conference.

Chen I, Moses T, Cuison K, Waineo E, Greenwald MK (2020) Previous healthcare experience improves attitudes toward opioid overdose among first-year medical students. WSUSOM Medical Education Research Conference.

Chou JC, Moses TE, Moreno J, Garmo M, Loveluck K, Ching K, Greenwald MK, Waineo E (2020) Baseline differences in learner characteristics affect learning outcomes of opioid overdose prevention and response training in undergraduate medical students. WSUSOM Medical Education Research Conference.

Chou JC, Moses TE, Moreno J, Garmo M, Loveluck K, Ching K, Greenwald MK, Waineo E (2020) Baseline differences in student attitude towards opioid overdose and individuals with substance use disorder contribute to opioid overdose prevention and response training outcomes. AAMC Regional Conference. Rapid City, South Dakota.

Culver L, Moses TEH, Baal P, Gloystein T, Syed S, Waineo E, Greenwald MK (2020) The impact of prior healthcare employment on first-year medical students’ knowledge and attitudes toward opioid use disorder. WSU Medical Education Research and Innovation Conference.

Dass SE, Moses TEH, Gockman K, Chitale A, Waineo E, Greenwald MK (2020) The impact of medical student specialty preference on opioid overdose knowledge and attitudes towards patients with opioid use disorder. WSU Medical Education Research and Innovation Conference. {oral presentation}

Dass SE, Moses TEH, Greenwald MK, Waineo E (2020) Exploring differences in attitudes toward the efficacy of the substance use disorder curriculum at the undergraduate medical level: what role does gender play? WSU Women in Medicine (WIM) Summit conference.

Faraj MM, Lipanski NM, Goldberg E, Marusak HA, Greenwald MK (2020) Reducing opioid craving, pain and stress in patients with opioid use disorder using martial arts-based virtual reality. Society of General Internal Medicine, Michigan Chapter, American College of Physicians conference.

Faraj MM, Lipanski NM, Goldberg E, Marusak HA, Greenwald MK (2020) A virtual reality martial arts-based intervention reduces pain, drug craving, and stress in patients with opioid use disorder. Medical Student Research Symposium, Wayne State University School of Medicine.

Fodor MC, Lundahl LH, Ledgerwood DM, Struble CA, Greenwald MK (2020) Sexual minority status and concurrent alcohol and cannabis use among male patients living with HIV/AIDS. Research Society on Alcoholism. [virtual presentation due to COVID-19]

Gockman K, Moses TEH, Chitale A, Waineo E, Greenwald MK (2020) The impact of medical student personal experiences with opioid overdose on knowledge and attitudes towards patients with substance use disorders. WSU Medical Education Research and Innovation Conference.

Greenwald MK (2020 June 17) The neurobiology of addiction: challenging what we know”, Indivior-sponsored livestream televised U.S. national broadcast.

Greenwald MK (2020) Effects of buprenorphine/naloxone maintenance dose on stress-reactivity in opioid use disorder. College on Problems of Drug Dependence [virtual presentation due to COVID-19].

Greenwald MK (2020 Aug 27) Buprenorphine extended-release (BUP-XR) in opioid use disorder: its foundation and promise. Invited presentation as part of Inside Practice webinar and discussion for Australia-wide addiction medicine practitioners, “All in good time: long-acting buprenorphine in opioid dependence: the promise and the practice”.

Greenwald MK (2020 Oct 28) The neurobiology of addiction: challenging what we know”, Indivior-sponsored livestream televised U.S. national broadcast, with Q&A session.

Klomparens K, Moses THE, Ching K, Baal P, Waineo E, Greenwald MK (2020) Positive regard towards patients with substance use disorders: Associations with confidence in opioid overdose response and attitudes towards naloxone distribution. WSU Medical Education Research and Innovation Conference. {oral presentation}

Lister JJ, Ellis J, Ledgerwood DM, Greenwald MK (2020) Psychosocial protective factors and methadone treatment outcomes: baseline predictors of first-month drug abstinence. Society for Social Work and Research conference.

Moses TEH, Chammaa M, Moreno J, Ramos R, Waineo E, Greenwald MK (2020) Opioid overdose prevention and response training for first year medical students: are improvements maintained after a year? American Academic of Addiction Psychiatry conference.

Moses TE, Chou J, Ramos R, Greenwald MK, Waineo E (2020) Medical education on substance use disorders and opioid overdose prevention and response: medical student perceptions and needs. AAMC national conference.

Moses TE, Moreno JL, Ramos R, Chammaa M, Waineo E, Greenwald MK (2020) Opioid overdose prevention and response training improves knowledge and attitudes toward opioid overdose and naloxone use in first year medical students. College on Problems of Drug Dependence [virtual presentation due to COVID-19].

Moses TEH, Moreno J, Ramos R, Waineo E, Greenwald MK (2020) Evaluating the unique impact of opioid overdose prevention and response training on medical student knowledge and attitudes toward opioid overdose. WSU College of Pharmacy Research Day.

Plantegenest G, Poland C, Strutz K, Bennett L, Greenwald MK, Heeringa C, Bunker H (2020) Building an innovative curricular intervention for addiction medicine certification. AAMC Central Group on Educational Affairs (CGEA) regional meeting. {cancelled due to COVID-19}

Syed S, Moses TEH, Culver L, El-Sayed W, Waineo E, Greenwald MK (2020) The role of race/ethnicity on knowledge of and attitudes towards opioid overdose and harm reduction. WSU Medical Education Research and Innovation Conference.

Tiura AJ, Anderson LA, Ondersma SJ, Nahum-Shani I, Greenwald MK, Naar S (2020) Developing an MHealth intervention to reduce heavy drinking and loss-of-control eating among college student women dating/sexual violence survivors. Research Society on Alcoholism (meeting cancelled).

2019

Andorn A, Haight B, Greenwald MK, Zhao Y, Fox NL, Heidbreder C, Learned S (2019) Higher abstinence rates with greater buprenorphine exposure among patients who inject opioids. Academy of Managed Care Pharmacy (AMCP) specialty meeting.

Arfken CL, Greenwald MK (2019) National treatment admissions with opioids and benzodiazepines as drugs of abuse. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Arfken, CL, Owens DD, Greenwald MK (2019) Opioids and benzodiazepines: national and local analysis. Accepted for presentation at the annual conference on Addiction Health Services Research.

Carr M†, Ellis JD, Saules K, Page J, Ledgerwood DM (submitted) Transdiagnostic addiction assessment in a methadone treatment sample. Abstract submitted for presentation at the 2020 Collaborative Perspectives on Addiction Meeting of Division on Addiction Psychology (50) of the American Psychological Association, San Diego, CA.

Ellis JD, Lister JJ, Ledgerwood DM, Fodor M, Struble CA (2019) Psychosocial correlates and treatment outcomes of methadone patients with a history of opioid overdose. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Fodor M, Struble CA, Ellis JD, Lundahl LH, Ledgerwood DM (2019) Sex differences in physical and mental health among people living with HIV/AIDS who smoke tobacco. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Greenwald MK (2019) Modulation of stress-induced opioid seeking by hedonic sensitivity. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX. {Oral presentation}

Greenwald MK (Oct 2019) Neuropharmacological foundation for the treatment of opioid use disorder. ATHS conference (International symposium “Addictions Drug Addiction Hepatitis AIDS), Biarritz France.

Greenwald MK (Oct 2019) Scientific development of extended release buprenorphine for the treatment of opioid addiction. FeDerSerD conference (Federazione Italiana degli Operatori dei Dipartmenti e dei Servizi delle Dipendenze [Italian Society of Addiction Medicine]), Milan Italy.

Greenwald MK (Nov 2019) What clinicians need to know about buprenorphine for effective treatment of opioid use disorder. Michigan Society of Addiction Medicine, Ypsilanti, MI.

Greenwald MK, Moses TEH, Gjini K, Boutros NN (2019) Cortical excitability in chronic cocaine users: relationship to clinical severity. WSU Translational Neuroscience Program Research Day.

Jacques-Tiura AJ, Greenwald MK, Anderson LA, Naar S (2019) Non-alcohol predictors of alcohol demand in college student women. Research Society on Alcoholism.

Karavidha K, Perrine SP, Burmeister M, Greenwald MK (2019) Beta-arrestin single nucleotide polymorphism associated with long term consequences of opioid use. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Ledgerwood DM (Aug 2019) Problem gambling provider Phase I training. Two-day workshop provided for the State of California Gambling Education and Treatment Services Program (CALGETS) and University of California - Los Angeles, Sacramento, CA.

Ledgerwood DM (Sept 2019) Reflecting on the past 15 years of collaboration with the Hotel Dieu – Grace Hosptial Centre for Problem Gambling and Digital Dependency. Invited presentation for the 30th anniversary of the CPGDD, Windsor, Ontario.

Ledgerwood DM (Oct 2019) Disordered thinking: The role of gambling-related cognitive distortions in the development and maintenance of gambling disorder and its treatment. Invited presentation for the Four Directions conference of the Evergreen Council on Problem Gambling, Anacortes, WA.

Ledgerwood DM (Oct 2019) When gambling is also a symptom of something else: Coping with co-occurring psychiatric disorders among problem gamblers seeking treatment. Invited presentation for the Four Directions conference of the Evergreen Council on Problem Gambling, Anacortes, WA.

Lien I, Moses TE, Chou J, Shango K, Dass S, Szpytman A, Greenwald MK (2019) Student led initiatives to incorporate addiction medicine training into undergraduate medical education in Detroit, MI. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Lister JJ, Ellis JD, Greenwald MK, Ledgerwood DM (2019) The relationship of psychosocial characteristics to co-occurring emotional problems among methadone patients. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Moses TEH, Chou J, Moreno J, Greenwald MK, Waineo E (2019) Investigating the long-term educational and community-level impacts of incorporating opioid overdose prevention and response training in undergraduate medical education. American Association of Medical Colleges (AAMC). National Harbor, MD.

Moses TEH, Greenwald MK (2019) Attenuated response to hydromorphone during buprenorphine stabilization associated with injection opioid use and quicker opioid lapse during buprenorphine dose tapering. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Moses TEH, Ramos R, Garmo M, Moreno J, Greenwald MK, Waineo E (2019) Efficacy of opioid overdose prevention and response training on medical student knowledge and attitudes. AMERSA (Association for Medical Education and Research in Substance Abuse) meeting.

Moses TEH, Ramos R, Garmo M, Waineo E, Greenwald MK (2019) Knowledge and attitudes changes toward opioid use disorder and naloxone use among medical students. American Association of Addiction Psychiatry.

Moses TEH, Woodcock EA, Diwadkar VA, Greenwald MK (2019) The role of baseline anxiety in associative learning and response to acute stress. Society for Neuroscience.

Struble CA, Ellis JD, Carr M, Ledgerwood DM, Lundahl LH (2019) Predictors of success in pregnant women receiving medication treatment for opioid use disorder. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX.

Woodcock EA, Diwadkar VA, Stanley JA, Khatib D, Greenwald MK (2019) Acute stress increases nicotine-seeking behavior and modulates smoking cue-reactivity among cigarette smokers. College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, TX. {Oral presentation}

2018

Greenwald, M.K., “How we got to extended-release buprenorphine, and why this is important for treatment of opioid use disorder”, Indivior Pharmaceuticals, Medical Affairs, Canada. Speaker tour engagements (multiple grand rounds presentations and roundtable discussions) with Canadian clinicians in Calgary and Vancouver (August 2018), and Montreal, Ottawa, Toronto, and London (September 2018)

Moses TEH, Burmeister M, Greenwald MK (2018) Heroin delay discounting and impulsivity: modulation by DRD1 genetic variation. Problems of Drug Dependence 2018: Proceedings of the 80th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

Greenwald MK, Burmeister M (2018) Variants in stress-signaling genes NR3C1 and FKBP5 modulate opioid abstinence during buprenorphine (BUP) stabilization and dose tapering. Problems of Drug Dependence 2018: Proceedings of the 80th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

Greenwald, M.K.,“Opioid overdose reversal and transition to treatment: pharmacological principles and evidence as a platform for protocol development”, NIDA Clinical Trials Network meeting, Rockville, MD, January 2018

2017

Moses TEH, Lundahl LH, Greenwald MK (2017) Factors associated with sedative use and misuse among regular heroin users. WSU Researchers of Biobehavioral Health in Urban Settings Today (RoBUST) 3rd annual meeting.

Greenwald MK, Jacques-Tiura AJ, Gothe N, Towner E, Bourbeau K, Naar S (2017) Effects of exercise intensity on executive cognitive function and food choice/consumption among obese adolescents. WSU Researchers of Biobehavioral Health in Urban Settings Today (RoBUST) 3rd annual meeting.

Tavakoli E, Deal E, Rhodes GL, Mischel E, Christensen C, Amirsadri A, Greenwald MK (2017) Retention and drug use among treatment-resistant patients transferred to a ‘Second Chance’ methadone maintenance treatment program. Problems of Drug Dependence 2017: Proceedings of the 79th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

Woodcock EA, Stanley JA, Diwadkar VA, Greenwald MK (2017) Effects of pharmacological stress-induction among non-treatment seeking cigarette smokers. Problems of Drug Dependence 2017: Proceedings of the 79th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

Arfken CL, Suchanek J, Rhodes G, Urbiel J, Greenwald MK (2017) Fentanyl in methadone-maintained treatment clients. Problems of Drug Dependence 2017: Proceedings of the 79th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc.

Ledgerwood, D.M. (2017) Predictors of smoking cessation initiation among people living with HIV/AIDS. Symposium presentation at the 51st Annual Convention, Association for Behavioral and Cognitive Therapies, San Diego, CA.

Lister, J.J., Brown, S., Greenwald, M.K., Ledgerwood, D.M. (2017). A precise investigation of African-American women in methadone treatment: gender differences and predictors of early-treatment drug use. Society for Social Work and Research 22nd Annual Conference - Achieving Equal Opportunity, Equity, and Justice. Washington, DC.

Lister, J.J., Greenwald, M.K., Ledgerwood, D.M. (2017) Psychosocial factors and methadone treatment outcomes among African-Americans: a substance abuse research program to address minority health disparities. University of Alabama at Birmingham, 12th Annual Health Disparities Research Symposium, Birmingham, AL.

Ledgerwood, D.M., Ostojic, D., McCarthy, J., Dyshniku, F., Forfitt, J., Rumble, S.C. (2017) How do cognitive distortions change during problem gambling treatment? Results from an archival study of residential gambling clients. Proceedings of the 31st Annual Conference, National Council on Problem Gambling, Portland, OR.

Drug Lab